Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin

Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin

Enterocytozoon bieneusi microsporidiosis is an emerging disease in immunocompromised patients. We report 2 cases of this disease in allogeneic hematopoietic stem cell transplant patients successfully treated with fumagillin. Thrombocytopenia occurred but without major adverse events. Modifications o...

Full description

Bibliographic Details
Main Authors: Iryna Bukreyeva, Adela Angoulvant, Inès Bendib, Jean-Charles Gagnard, Jean-Henri Bourhis, Sylvie Dargère, Julie Bonhomme, Marc Thellier, Bertrand Gachot, Benjamin Wyplosz
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2017-06-01
Series:Emerging Infectious Diseases
Subjects:
Enterocytozoon bieneusi
protozoa
microsporidia
microsporidiosis
parasites
obligate intracellular parasite
Online Access:https://wwwnc.cdc.gov/eid/article/23/6/16-1825_article

Internet

https://wwwnc.cdc.gov/eid/article/23/6/16-1825_article

Similar Items